High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed and Refractory Classical Hodgkin Lymphoma

Introduction:Programmed death-1 (PD-1) inhibitors are highly active in relapsed and refractory (RR) classical Hodgkin lymphoma (cHL), however their role as part of second-line therapy (SLT) for cHL is largely unexplored. The standard approach following front-line treatment failure is SLT, aimed to a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2019-11, Vol.134 (Supplement_1), p.2837-2837
Hauptverfasser:	Moskowitz, Alison J., Shah, Gunjan L., Schoder, Heiko, Hancock, Helen, Davey, Theresa, Joong, Christopher, Pomerantz, Lauren, Jarjies, Christine, Kumar, Anita, Lahoud, Oscar B, Batlevi, Connie Lee, Hamlin, Paul A., Straus, David J., Rodriguez-Rivera, Ildefonso, Owens, Colette, Caron, Philip, Colbourn, Donald Steven, Intlekofer, Andrew M., Hamilton, Audrey, Horwitz, Steven M., Joffe, Erel, Palomba, M. Lia, Noy, Ariela, Matasar, Matthew J, Vardhana, Santosha, von Keudell, Gottfried R., Yahalom, Joachim, Younes, Anas, Zelenetz, Andrew D., Moskowitz, Craig H.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!